39030577|t|Alpha-lipoic acid alleviates cognitive deficits in transgenic APP23/PS45 mice through a mitophagy-mediated increase in ADAM10 alpha-secretase cleavage of APP.
39030577|a|BACKGROUND: Alpha-lipoic acid (ALA) has a neuroprotective effect on neurodegenerative diseases. In the clinic, ALA can improve cognitive impairments in patients with Alzheimer's disease (AD) and other dementias. Animal studies have confirmed the anti-amyloidosis effect of ALA, but its underlying mechanism remains unclear. In particular, the role of ALA in amyloid-beta precursor protein (APP) metabolism has not been fully elucidated. OBJECTIVE: To investigate whether ALA can reduce the amyloidogenic effect of APP in a transgenic mouse model of AD, and to study the mechanism underlying this effect. METHODS: ALA was infused into 2-month-old APP23/PS45 transgenic mice for 4 consecutive months and their cognitive function and AD-like pathology were then evaluated. An ALA drug concentration gradient was applied to 20E2 cells in vitro to evaluate its effect on the expression of APP proteolytic enzymes and metabolites. The mechanism by which ALA affects APP processing was studied using GI254023X, an inhibitor of A Disintegrin and Metalloproteinase 10 (ADAM10), as well as the mitochondrial toxic drug carbonyl cyanide m-chlorophenylhydrazone (CCCP). RESULTS: Administration of ALA ameliorated amyloid plaque neuropathology in the brain tissue of APP23/PS45 mice and reduced learning and memory impairment. ALA also increased the expression of ADAM10 in 20E2 cells and the non-amyloidogenic processing of APP to produce the 83 amino acid C-terminal fragment (C83). In addition to activating autophagy, ALA also significantly promoted mitophagy. BNIP3L-knockdown reduced the mat/pro ratio of ADAM10. By using CCCP, ALA was found to regulate BNIP3L-mediated mitophagy, thereby promoting the alpha-cleavage of APP. CONCLUSIONS: The enhanced alpha-secretase cleavage of APP by ADAM10 is the primary mechanism through which ALA ameliorates the cognitive deficits in APP23/PS45 transgenic mice. BNIP3L-mediated mitophagy contributes to the anti-amyloid properties of ALA by facilitating the maturation of ADAM10. This study provides novel experimental evidence for the treatment of AD with ALA.
39030577	0	17	Alpha-lipoic acid	Chemical	MESH:D008063
39030577	29	47	cognitive deficits	Disease	MESH:D003072
39030577	68	72	PS45	CellLine	CVCL:G253
39030577	73	77	mice	Species	10090
39030577	171	188	Alpha-lipoic acid	Chemical	MESH:D008063
39030577	190	193	ALA	Chemical	MESH:D008063
39030577	227	253	neurodegenerative diseases	Disease	MESH:D019636
39030577	270	273	ALA	Chemical	MESH:D008063
39030577	286	307	cognitive impairments	Disease	MESH:D003072
39030577	311	319	patients	Species	9606
39030577	325	344	Alzheimer's disease	Disease	MESH:D000544
39030577	346	348	AD	Disease	MESH:D000544
39030577	360	369	dementias	Disease	MESH:D003704
39030577	410	421	amyloidosis	Disease	MESH:D000686
39030577	432	435	ALA	Chemical	MESH:D008063
39030577	510	513	ALA	Chemical	MESH:D008063
39030577	630	633	ALA	Chemical	MESH:D008063
39030577	693	698	mouse	Species	10090
39030577	708	710	AD	Disease	MESH:D000544
39030577	772	775	ALA	Chemical	MESH:D008063
39030577	827	831	mice	Species	10090
39030577	890	892	AD	Disease	MESH:D000544
39030577	932	935	ALA	Chemical	MESH:D008063
39030577	979	983	20E2	CellLine	CVCL:A5CZ
39030577	1107	1110	ALA	Chemical	MESH:D008063
39030577	1152	1161	GI254023X	Chemical	MESH:C555398
39030577	1179	1217	A Disintegrin and Metalloproteinase 10	Gene	11487
39030577	1219	1225	ADAM10	Gene	11487
39030577	1243	1256	mitochondrial	Disease	MESH:D028361
39030577	1268	1308	carbonyl cyanide m-chlorophenylhydrazone	Chemical	MESH:D002258
39030577	1310	1314	CCCP	Chemical	MESH:D002258
39030577	1344	1347	ALA	Chemical	MESH:D008063
39030577	1360	1389	amyloid plaque neuropathology	Disease	MESH:D058225
39030577	1424	1428	mice	Species	10090
39030577	1441	1471	learning and memory impairment	Disease	MESH:D007859
39030577	1473	1476	ALA	Chemical	MESH:D008063
39030577	1510	1516	ADAM10	Gene	11487
39030577	1520	1524	20E2	CellLine	CVCL:A5CZ
39030577	1668	1671	ALA	Chemical	MESH:D008063
39030577	1711	1717	BNIP3L	Gene	12177
39030577	1740	1743	mat	Gene	11720
39030577	1757	1763	ADAM10	Gene	11487
39030577	1774	1778	CCCP	Chemical	MESH:D002258
39030577	1780	1783	ALA	Chemical	MESH:D008063
39030577	1806	1812	BNIP3L	Gene	12177
39030577	1939	1945	ADAM10	Gene	11487
39030577	1985	1988	ALA	Chemical	MESH:D008063
39030577	2005	2023	cognitive deficits	Disease	MESH:D003072
39030577	2049	2053	mice	Species	10090
39030577	2055	2061	BNIP3L	Gene	12177
39030577	2105	2112	amyloid	Disease	MESH:C000718787
39030577	2127	2130	ALA	Chemical	MESH:D008063
39030577	2165	2171	ADAM10	Gene	11487
39030577	2242	2244	AD	Disease	MESH:D000544
39030577	2250	2253	ALA	Chemical	MESH:D008063
39030577	Positive_Correlation	MESH:D008063	11487
39030577	Association	MESH:D008063	12177
39030577	Association	11487	12177
39030577	Association	MESH:D008063	MESH:C000718787
39030577	Association	MESH:C000718787	12177
39030577	Positive_Correlation	11720	12177
39030577	Association	MESH:D002258	12177
39030577	Negative_Correlation	MESH:D002258	MESH:D028361
39030577	Negative_Correlation	MESH:D008063	MESH:D000686
39030577	Negative_Correlation	MESH:D008063	MESH:D007859
39030577	Negative_Correlation	MESH:D008063	MESH:D003072
39030577	Negative_Correlation	MESH:D008063	MESH:D000544
39030577	Negative_Correlation	MESH:D008063	MESH:D003704
39030577	Negative_Correlation	MESH:D008063	MESH:D019636
39030577	Negative_Correlation	MESH:C555398	11487
39030577	Negative_Correlation	MESH:D008063	MESH:D058225

